SCHEMBL29922720

SCHEMBL29922720

CCCCC1=Cc2ccccc2C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.49
HTR2A P28223 2/20 0.49
HTR7 P34969 2/20 0.49
DRD3 P35462 2/20 0.49
HTR2B P41595 2/20 0.49
ACHE P22303 1/20 0.47
PTGS2 P35354 2/20 0.37
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
DRD2 P14416 2/20 0.36
HTR2C P28335 1/20 0.36
HRH1 P35367 1/20 0.36
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
SIGMAR1 Q99720 1/20 0.34
PREP P48147 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7195698 1.00 HTR1A (0.49) HTR1AHTR2AHTR7DRD3HTR2B
SCHEMBL5613920 0.95 HTR2A (0.48) HTR1AHTR2AHTR7DRD3HTR2B
SCHEMBL29922564 0.93 HTR2A (0.47) HTR1AHTR2AHTR7DRD3HTR2B
SCHEMBL1539753 0.89 HTR1A (0.51) HTR1AHTR2AHTR7DRD3HTR2B
SCHEMBL737837 0.88 HTR1A (0.54) HTR1AHTR2AHTR7DRD3HTR2B
SCHEMBL7566441 0.86 HTR1A (0.53) HTR1AHTR2AHTR7DRD3HTR2B
SCHEMBL577446 0.84 HTR1A (0.57) HTR1AHTR2AHTR7DRD3HTR2B
SCHEMBL8729000 0.84 SIGMAR1 (0.45) HTR1AHTR2AHTR7DRD3HTR2B
SCHEMBL5064672 0.82 ACHE (0.39) HTR1AHTR2AHTR7DRD3HTR2B
SCHEMBL28759275 0.82 CYP3A4 (0.40) HTR1AHTR2AHTR7DRD3HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11492425-B2 Metallocene catalyst compositions and polymerization process therewith EXXONMOBIL CHEMICAL PATENTS INC. (US) 2022-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11492425-B2 Metallocene catalyst compositions and polymerization process therewith TERT, MDM4, PCBP1 HTR1A 2370/4885HTR2A 2519/4885HTR7 3878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.